How Do T Cells Respond to Viral Infection and Vaccination

A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Cellular/Molecular Immunology".

Deadline for manuscript submissions: closed (30 November 2023) | Viewed by 260

Special Issue Editor

Center for Biomedical Research, University of Texas Health Center at Tyler, Tyler, TX, USA
Interests: vaccine development; virus-host interaction; HIV immunology; gene editing and gene therapy; phage therapy; humanized mouse models
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

T cell immunity plays a crucial role in recognizing and controlling intracellular viruses and is an essential arm of immune protection against viral infections. After viral infections or vaccinations, T cell responses develop early and correlate with protection by limiting disease severity and enhancing vaccine efficacy. Generally, the primary T cell responses include antigen processing and binding to MHC molecules, antigen presentation by Dendritic cells and macrophages (antigen-presenting cells) to cytotoxic T cells, T cell activation, proliferation, differentiation, cytokine production, and production of effective molecules to perform their roles in immune responses. On the other hand, CD4+ helper T cells support B cell responses in the germinal center, and also have direct antiviral properties. Moreover, T cell memory is established after viral infection and vaccination, and it contributes to the long-term protection of viral infection. A variety of immune cell types and molecules are involved in the T cell immunity, while for distinct viruses and vaccinations, the T immune responses vary, resulting in different protection outcomes. Most studies of viral infections and vaccinations, especially for SARS-CoV-2 infections and vaccinations, focused on B cell responses (antibody responses). Given the equal importance of T cell immunity in viral infections and vaccinations, we believe the following aspects of T cell immunity should be extensively investigated and would also be of broad interest to the readers of Vaccines

  1. T cell immunity characterization after viral infection using human cohorts.
  2. T cell-based vaccines and their efficacy in appropriate animal models;
  3. The precise mechanisms by which T cell responses contribute to protection after viral infections and vaccinations. For example, the memory T cells‘ response, the roles of resident memory T cells, viral escape from T cell immunity, etc.
  4. T cell epitope characterization and test the potential for vaccine development;
  5. Identify the novel T cell subsets or the novel functions of the existing T cell subsets during viral infections.
  6. TCR profiling after viral infections or vaccinations using high-throughput T cell receptor (TCR) sequencing technology;
  7. The novel techniques to characterize the T cell immune responses.
  8. Any other studies related to T cell responses to viral infections and vaccinations. 

Dr. Guohua Yi
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • T cells
  • viral infection
  • vaccination
  • vaccine development
  • immunity
  • T cell based-vaccine
  • vaccine efficacy
  • antigen presentation
  • T cell epitope
  • T cell receptor
  • TCR sequencing
  • T cell subsets
  • memory T cells

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop